Elevance Health Inc. (ELV)
| Market Cap | 114.09B |
| Revenue (ttm) | 153.25B |
| Net Income (ttm) | 6.21B |
| Shares Out | 238.83M |
| EPS (ttm) | 25.50 |
| PE Ratio | 18.73 |
| Forward PE | 15.90 |
| Dividend | $5.12 (1.07%) |
| Ex-Dividend Date | Dec 2, 2022 |
| Volume | 992,036 |
| Open | 481.19 |
| Previous Close | 480.41 |
| Day's Range | 476.44 - 487.37 |
| 52-Week Range | 432.03 - 549.52 |
| Beta | 0.89 |
| Analysts | Buy |
| Price Target | 590.09 (+23.53%) |
| Earnings Date | Jan 25, 2023 |
About ELV
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana. [Read more]
Financial Performance
In 2021, ELV's revenue was $138.64 billion, an increase of 13.76% compared to the previous year's $121.87 billion. Earnings were $6.10 billion, an increase of 33.51%.
Financial StatementsAnalyst Forecast
According to 27 analysts, the average rating for ELV stock is "Buy." The 12-month stock price forecast is $590.09, which is an increase of 23.53% from the latest price.
News
Elevance Health (ELV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Elevance Health (ELV) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wa...
Elevance Health's 2.750% Senior Convertible Debentures due 2042 to Accrue Contingent Interest
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) announced today that for the six-month interest period commencing on October 15, 2022, its 2.750% Senior Convertible Debentures due 2...
Elevance Health (ELV) Tops on Q4 Earnings, Hikes Dividend
Elevance Health's (ELV) fourth-quarter earnings gain on solid premiums from its Medicaid business. Management approves a quarterly dividend hike of 16%.
Elevance Health (ELV) Surpasses Q4 Earnings Estimates
Elevance Health (ELV) delivered earnings and revenue surprises of 0.58% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Elevance Health Reports Fourth Quarter and Full Year 2022 Results
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2022 results reflecting strong financial performance, including double-digit growth in revenue,...
AM Best Comments on Credit Ratings of Elevance Health, Inc. and Its Subsidiaries Following Acquisition Announcement
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has commented that the Credit Ratings (ratings) of Elevance Health, Inc. (Elevance) (Indianapolis, IN) [NYSE: ELV] and its insurance subsidiaries entities rem...
Elevance to Acquire Louisiana Nonprofit Health Insurer
Terms of the deal weren't disclosed. Blue Cross and Blue Shield of Louisiana has about 1.9 million members.
Elevance Health to Acquire Blue Cross and Blue Shield of Louisiana
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) and Blue Cross and Blue Shield of Louisiana announced today that the companies have entered into a definitive agreement through which...
Elevance Health (ELV) to Post Q4 Earnings: What to Expect
Elevance Health's (ELV) fourth-quarter results are likely to reflect higher premiums, Commercial & Specialty Business' sales and total expenses.
Elevance Health, Cigna's stocks gain
Shares of several health insurers rallied in trading on Friday after UnitedHealth Group Inc. UNH, +1.79% reported better-than-expected profit and revenue in the fourth quarter of 2022. Elevance Health...
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review ...
Why You Should Hold Elevance Health (ELV) in Your Portfolio
Elevance Health (ELV) remains well-poised for growth due to a growing customer base within its Government and IngenioRx businesses coupled with solid cash-generating abilities.
ELV vs. PGNY: Which Stock Is the Better Value Option?
ELV vs. PGNY: Which Stock Is the Better Value Option?
Elevance: A Standout Health Care Stock
Health care has been a nightmare of a place to invest in over the last year. One area of the health care space that has withstood the sharp declines, however, are those companies that operate in the m...
Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year?
Here is how Elevance Health (ELV) and Genmab AS Sponsored ADR (GMAB) have performed compared to their sector so far this year.
Andreas Halvorsen's Top 5 Trades of the 3rd Quarter
Viking Global Investors LP, the firm founded by Andreas Halvorsen (Trades, Portfolio), disclosed in a regulatory filing that its top five trades during the third quarter included the closure of its po...
3 Top-Ranked Large-Caps With Big Growth
Large-cap stocks are a staple in every portfolio. They're well-established, have greater analyst coverage, typically pay dividends, and help shield investors from volatility.
The Most-Sold Guru Stocks of the 3rd Quarter
The third quarter of 2022 was another discouraging period for investors. Inflation kept going strong, the Federal Reserve continued raising interest rates and even the housing market began showing sig...
Factors That Make Elevance Health (ELV) a Lucrative Bet Now
Elevance Health (ELV) continues to benefit from sustained top-line growth, higher membership in Government business and a sturdy financial position.
ELV vs. PGNY: Which Stock Should Value Investors Buy Now?
ELV vs. PGNY: Which Stock Is the Better Value Option?
Twenty-one Elevance Health Medicaid Plans Receive NCQA Health Equity Accreditation
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) announced today that 21 of its affiliated Medicaid plans are the first in the nation to earn a full three-year accreditation for heal...
Is Elevance Health, Inc. (ELV) Outperforming Other Medical Stocks This Year?
Here is how Elevance Health (ELV) and Genmab AS Sponsored ADR (GMAB) have performed compared to their sector so far this year.
Why Is Elevance Health (ELV) Down 5% Since Last Earnings Report?
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?